Work

Supplementary Table Legend from Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table Legend

DOI: 10.1158/1078-0432.22474584.v1

Authors: Siwen Hu-Lieskovan, Aaron Lisberg, Jesse M. Zaretsky, Tristan R. Grogan, Hira Rizvi, Daniel K. Wells, James Carroll, Amy Cummings, John Madrigal, Benjamin Jones, Jacklin Gukasyan, I. Peter Shintaku, Dennis Slamon, Steven Dubinett, Jonathan W. Goldman, David Elashoff, Matthew D. Hellmann, Antoni Ribas, Edward B. Garon

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361936752

Cites:

Cited by:

Related to: 10